Cytochrome P450 2B6 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-57978
Key Product Details
Species Reactivity
Human, Mouse
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
0.5 mg/ml
Product Specifications
Immunogen
Synthetic peptides corresponding to CYP2B6(cytochrome P450, family 2, subfamily B, polypeptide 6) The peptide sequence was selected from the middle region of CYP2B6.
Peptide sequence QLFELFSGFLKYFPGAHRQVYKNLQEINAYIGHSVEKHRETLDPSAPKDL. The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Description
The addition of 50% glycerol is optional for those storing this antibody at -20C and not aliquoting smaller units. However, please note that glycerol may interrupt some downstream antibody applications and should be added with caution.
Scientific Data Images for Cytochrome P450 2B6 Antibody
Western Blot: Cytochrome P450 2B6 Antibody [NBP1-57978]
Western Blot: Cytochrome P450 2B6 Antibody [NBP1-57978] - THP-1 cell lysate, concentration 0.2-1 ug/ml.Applications for Cytochrome P450 2B6 Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: Cytochrome P450 2B6
Long Name
Cytochrome P450 2B6
Alternate Names
CYP2B6, CYPIIB6, EC 1.14.13.-
Gene Symbol
CYP2B6
UniProt
Additional Cytochrome P450 2B6 Products
Product Documents for Cytochrome P450 2B6 Antibody
Product Specific Notices for Cytochrome P450 2B6 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...